Friday, July 10, 2026

Intelligence · Clinical pipeline

Autoimmune & immunology · Phase III

Autoimmune & immunology programs at Phase III — ClinicalTrials.gov pipeline intelligence.

Programs 368

Quick answer

Autoimmune & immunology Phase III programs: NovaPharmaNews indexes 368 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Pipeline programs

Page 3 of 8
  1. CVAY736F12302

    Novartis Pharmaceuticals

    Systemic Lupus Erythematosus

    phase 3 small molecule active

    1 trial
  2. CVAY736K12301

    Novartis Pharmaceuticals

    Lupus nephritis

    phase 3 small molecule active

    1 trial
  3. CVAY736K12301E1

    Novartis Pharmaceuticals

    Lupus nephritis

    phase 3 small molecule active

    1 trial
  4. CVAY736O12301

    Novartis Pharmaceuticals

    warm autoimmune haemolytic anaemia (wAIHA)

    phase 3 small molecule active

    1 trial
  5. Cardioblate® Surgical Ablation System

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatic Valve Disease

    phase 3 other active

    1 trial
  6. Cenerimod

    Viatris Pharmaceuticals Co.,

    Lupus Erythematosus, Systemic

    phase 3 small molecule active

    2 trials
  7. Cenerimod 4 mg

    Viatris Pharmaceuticals Co.,

    Systemic lupus erythematosus

    phase 3 small molecule active

    1 trial
  8. Cenerimod 4 mg, Cenerimod matching placebo

    Viatris Pharmaceuticals Co.,

    Moderate to severe systemic lupus erythematosus

    phase 3 small molecule active

    1 trial
  9. Cenerimod matching placebo, Cenerimod 4 mg

    Viatris Pharmaceuticals Co.,

    Moderate to severe systemic lupus erythematosus

    phase 3 small molecule active

    1 trial
  10. Cx601

    Takeda

    Crohn's Disease

    phase 3 other completed

    3 trials
  11. D346BC00001

    AstraZeneca AB

    Cutaneous Lupus Erythematosus

    phase 3 small molecule active

    1 trial
  12. Darvadstrocel

    Takeda

    Complex Perianal Fistulas in Adult Participants With Crohn's Disease

    phase 3 mab completed

    1 trial
  13. Delayed and extended release mesalazine

    Takeda

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial
  14. Dexamethasone

    Quince Therapeutics

    Crohn's Disease

    phase 3 small molecule terminated

    1 trial
  15. Diclofenac Sodium Topical Gel, 1%

    Amneal Pharma Europe Ltd

    Osteoarthritis

    phase 3 small molecule completed

    1 trial
  16. Donepezil

    Universal Integrated

    Osteoarthritis

    phase 3 small molecule active

    1 trial
  17. Double-blind 200 mg imsidolimab

    Vanda Pharmaceuticals Netherlands B.V.

    Generalized Pustular Psoriasis

    phase 3 small molecule terminated

    1 trial
  18. Duloxetine

    Pacira Ireland Limited

    Knee Osteoarthritis

    phase 3 small molecule completed

    1 trial
  19. Duvakitug

    Teva Pharma GmbH

    Ulcerative Colitis

    phase 3 small molecule active

    2 trials
  20. Duvakitug

    Teva Pharma GmbH

    Crohn's Disease

    phase 3 small molecule active

    2 trials
  21. EFC17360 - LUMINA 3

    Sanofi-aventis Healthcare Pty Ltd

    Autoimmune haemolytic anaemia

    phase 3 small molecule active

    1 trial
  22. EFGARTIGIMOD ALFA, JNJ-80202135

    Janssen-Cilag International N.V.

    generalized myasthenia gravis

    phase 3 small molecule active

    1 trial
  23. Enbrel solution for injection in pre-filled s... for Chronic Plaque Psoriasis

    Janssen-Cilag International N.V.

    Chronic Plaque Psoriasis

    phase 3 small molecule active

    1 trial
  24. Etanercept

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Rheumatoid Arthritis

    phase 3 small molecule active

    1 trial
  25. Etanercept

    Coherus Oncology

    Plaque Psoriasis

    phase 3 small molecule completed

    1 trial
  26. Etanercept

    Coherus Oncology

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial
  27. Etrasimod Arginine Blue

    Lacuna Pharma Pty Ltd

    Ulcerative Colitis

    phase 3 small molecule active

    1 trial
  28. FX006

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    2 trials
  29. FX006

    Pacira Ireland Limited

    Osteoarthritis, Hip

    phase 3 small molecule terminated

    1 trial
  30. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis of the Knee

    phase 3 small molecule completed

    4 trials
  31. FX006 32 mg

    Pacira Ireland Limited

    Osteoarthritis, Knee

    phase 3 small molecule completed

    1 trial
  32. Fasinumab

    Regeneron UK Limited

    Osteoarthritis, Knee

    phase 3 small molecule completed

    4 trials
  33. Fasinumab

    Regeneron UK Limited

    Osteoarthritis of the Knee or Hip

    phase 3 small molecule completed

    1 trial
  34. Filgotinib

    Alfasigma S.p.A.

    Axial Spondyloarthritis

    phase 3 small molecule active

    1 trial
  35. Filgotinib

    Lakefront Biotherapeutics NV

    Psoriatic Arthritis

    phase 3 small molecule terminated

    4 trials
  36. Filgotinib

    Lakefront Biotherapeutics NV

    Crohn's Disease

    phase 3 small molecule completed

    2 trials
  37. Filgotinib

    Lakefront Biotherapeutics NV

    Ulcerative Colitis

    phase 3 small molecule completed

    2 trials
  38. Fostamatinib disodium

    RIGEL PHARMACEUTICALS INC

    Warm Antibody Autoimmune Hemolytic Anemia

    phase 3 small molecule active

    2 trials
  39. GLPG0634-CL-329

    Alfasigma S.p.A.

    Polyarticular-course juvenile idiopathic arthritis

    phase 3 small molecule active

    1 trial
  40. GLPG0634-CL-331

    Alfasigma S.p.A.

    Ulcerative colitis

    phase 3 small molecule active

    1 trial
  41. GLPG0634-CL-333

    Alfasigma S.p.A.

    Juvenile idiopathic arthritis

    phase 3 small molecule active

    1 trial
  42. GS-US-417-0304

    Alfasigma S.p.A.

    Rheumatoid arthritis

    phase 3 small molecule active

    1 trial
  43. GS-US-418-3899

    Alfasigma S.p.A.

    Ulcerative Colitis (UC)

    phase 3 small molecule active

    1 trial
  44. GSK1605786A

    GlaxoSmithKline

    Crohn's Disease

    phase 3 small molecule terminated

    2 trials
  45. GSK3196165 (Otilimab)

    GlaxoSmithKline

    Arthritis, Rheumatoid

    phase 3 mab completed

    1 trial
  46. GW406381

    GlaxoSmithKline

    Osteoarthritis, Knee

    phase 3 small molecule completed

    1 trial
  47. Gefurulimab

    Alexion Europe SAS

    Generalized Myasthenia Gravis with autoantibodies against acetylcholine receptor (AChR)

    phase 3 small molecule active

    1 trial
  48. Golimumab 1 mg per kg

    Janssen Cilag International NV

    Colitis, Ulcerative

    phase 3 small molecule terminated

    1 trial

Frequently asked questions

How many autoimmune & immunology Phase III programs exist?

368 programs match both the therapeutic area and stage filters in our published index.